Quick Facts
  • Primary Location:
    Stanford Cancer Institute
  • Expertise:
    Pleural and Lung Cancer
  • Speciality:
    Medical Oncology
  • Gender:
  • Language:
  • Med School:
    Johns Hopkins University School of Medicine

Get to Know Dr. Heather Wakelee

Dr. Heather Wakelee is a professor of medicine at Stanford University in the Division of Thoracic Oncology and a lead investigator for the ECOG-ACRIN clinical trials group at the Stanford Cancer Institute.

She has studied, written and spoken extensively on mesothelioma treatment and non-small cell lung cancer; on why female lung cancer patients survive longer; on sex differences in susceptibility, biology and therapeutic responses to lung cancer; and novel cytotoxic agents in lung cancer. She also specializes in the treatment of pleural mesothelioma with oncology drugs such as chemotherapy.

Wakelee often tells her patients that chemotherapy is not for everyone, but that undergoing it usually improves their chances of avoiding cancer again by 5% to 10%.

“When I talk with [patients] about what we can do to improve cure rates, the only thing that we know that has an impact is chemotherapy, and it’s not an easy chemotherapy,” Wakelee said. “Most people can get through it, but it’s challenging.”

Wakelee earned her medical degree at Johns Hopkins University School of Medicine. Her residency was through the Stanford University Internal Medicine Program, and her fellowship was at Stanford University’s Division of Oncology.

Contact Heather Wakelee
By submitting, you agree to our privacy policy and disclaimer. Our Patient Advocates may contact you via phone, email and/or text.

Specialties of Dr. Heather Wakelee

  • Pleural and lung cancer
  • Research
  • Internal medicine
Mesothelioma specialist speaking with a patient and his wife
Talk to a Doctor About Your Diagnosis
We can help you or a loved one get in contact with Dr. Wakelee and find the treatment that’s best for you.

Dr. Heather Wakelee’s Experience and Medical Education

  • Johns Hopkins University School of Medicine (M.D.)
  • Stanford University Internal Medicine Program (Residency)
  • Stanford University Division of Oncology (Fellowship)

Awards and Certifications

  • Young Investigator Award, ECOG-ACRIN (2015)
  • Teaching Award, Stanford University Division of Oncology (2007-2009 and 2011)
  • Merit Award, American Society of Clinical Oncology (2003)
  • Alpha Omega Alpha, Johns Hopkins University (1996)
  • Board certified in internal medicine

Publications of Dr. Heather Wakelee

  • Garassino, M.C. et al. (2020, July 1). COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. The Lancet Oncology.
  • Whisenant, J.G. et al. (2020, June 8). TERAVOLT: Thoracic Cancers International COVID-19 Collaboration. Cancer Cell.
  • Chabon, J.J. et al. (2020, March 25). Integrating genomic features for non-invasive early lung cancer detection. Nature.

Laptop with screen video conference on kitchen counter
Browse Our Free Mesothelioma Webinars
United States one-hundred-dollar bills
Access More than $32 Billion in Trust Funds
Technician documenting notes in a lab
Find Active Mesothelioma Clinical Trials

Tell us what you think
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?